Small-cell undifferentiated (neuroendocrine) carcinoma of the nasal cavity treated with concurrent chemoradiotherapy including irinotecan and cisplatin

This is a case report of a 58-year-old woman with advanced small-cell undifferentiated (neuroendocrine) carcinoma of the nasal cavity treated with concurrent chemoradiotherapy (CCRT) with irinotecan and cisplatin. No recurrence has been observed more than 5 years after treatment. CCRT with irinotecan and cisplatin is regarded as effective for neuroendocrine small-cell carcinoma of the nasal cavity.